“…Fgf4 specifically labels EPI cells during blastocyst formation (Kurimoto et al, 2006;Guo et al, 2010;Frankenberg et al, 2011;Ohnishi et al, 2014) and is not expressed in Nanog mutants (Frankenberg et al, 2011). Fgfr2 is expressed in all early ICM cells at E3.25 before its restriction to PE cells by E3.5, suggesting that all early ICM cells are capable of responding to FGF ligands (Ohnishi et al, 2014;Boroviak et al, 2015). Blocking FGF signalling is sufficient for all ICM cells to adopt an EPI fate (Chazaud et al, 2006;Nichols et al, 2009;Yamanaka et al, 2010;Kang et al, 2013;Krawchuk et al, 2013), whereas the addition of excess FGF4 is sufficient to differentiate all ICM cells into PE .…”